PR, Media News, Client Updates & Observations from Absolutely PR in Denver

_______________________________________________

Follow on Twitter (since June 2008): www.twitter.com/DenverPR
Read Client Pitches & Placements (since July 2005): http://denverpr.blogspot.com
Checkout Denver PR Newsroom (since March 2002): www.DenverPRNewsroom.com

HOMECONTACTLeadershipBrand ExperienceNewsSocial/Digital MediaE-PortfolioResultsOnline ExposureWhy PR?How PR?News HooksBlog - UpdatesIRPR.US

Wednesday, October 22, 2014

CBSA Announces Finalists for 2014 Company of the Year and Rising Star of the Year Awards
The Colorado BioScience Association (CBSA) has chosen the finalists for the 2014 “Company of the Year” and “Rising Star” Awards, which they will present during theAnnual Awards Dinner held on Thursday, November 6, at the Marriott City Center, 1701 California Street, Denver, CO. The announcement is made by April Giles, CBSA President and CEO, who says the finalists selected are companies that have made successful achievements over the past year, showing the promise and breadth of the industry in the state. The winner of each award will be announced during the November 6th event.

Company of the Year Finalists: 

This award is designated for an established company that has announced a significant advancement within the year.

AlloSource - Centennial -http://www.allosource.org

Mountainside Medical - Boulder - http://mountainsidemed.com

Spectranetics - Colorado Springs - http://www.spectranetics.com

Rising Star of the Year Finalists: 

This award is designated for an emerging company that has announced an achievement within the year.

JustRight Surgical - Boulder -http://www.justrightsurgical.com

Silvergate Pharmaceuticals - Greenwood Village -http://www.silvergatepharma.com

Virocyt - Boulder - http://virocyt.com

In addition to Company of the Year and Rising Star, this year’s Bioscience Industry Awards also include:

* Lifetime Achievement
* Institute Leadership
* Business Partner of the Year
* Educator of the Year
* Volunteer of the Year
* Chairman’s Award

The Awards Dinner, emceed by 850 KOA Morning News Anchor Steffan Tubbs, will begin with a cocktail reception followed by dinner and a dynamic program. CBSA will first recognize those companies and individuals who are making a significant difference in Colorado’s vibrant bioscience industry. The Boettcher Foundation will then present the 2014 Class of Boettcher Investigators in the Webb-Waring Biomedical Research Program. The event closes with a keynote address by Olympic cycling medalist and Parkinson’s survivor Davis Phinney. 

Phinney, diagnosed with Parkinson’s disease in 2000 at the age of 40, founded the Boulder-based Davis Phinney Foundation in 2004. Today, Phinney is both a role model in the cycling community and an inspiration to the estimated 1.5 million Americans and estimated 10 million worldwide who are currently living with the disease. Tens of thousands of people living with this disease have been directly touched by one of the Davis Phinney Foundation programs or through Davis Phinney’s inspirational message: “it is possible to live well with Parkinson’s today.” For more information, visit: http://www.davisphinneyfoundation.org andhttp://www.medtronicdbs.com/parkinsons/personal-stories/davis-phinney/index.htm.

Tickets for the Awards Dinner are available for purchase at the CBSA website. Individual tickets are $150. Tables (8 seats) are available for $1,250 for CBSA members and $1,500 for non-CBSA members. Please note: the Awards Dinner was a sellout event last year, so do not delay securing arrangements. Visit:http://www.cobioscience.com/events-calendar/awards-dinner-2014.

Sponsorships for the Awards Dinner are also still available. Those interested in sponsorships should contact Tracey Nilson at tnilson@cobioscience.com no later than close of business Friday, October 24. Sponsors, as of the date of this release, include: Boettcher Foundation; Cooley, LLP; Fisher Scientific, Fitzsimons Redevelopment Authority, Medtronic and Terumo BCT.

Link to the Business Wire Newswire 

Link to the PitchEngine Social Media Release
4:50 pm edt          Comments

CBSA Honors Industry's Best + Features Olympian/Parkinson's Survivor Davis Phinney As Keynote
CBSA will host its Annual Awards Dinner on November 6 at the Denver Marriott City Center. The announcement is made by April Giles, CBSA President and CEO, who says, “We are thrilled to again celebrate the success of Colorado’s bioscience industry and recognize those standout companies and individuals who have contributed significantly to the growth of our community this year. Further, we are fortunate to welcome Olympic medalist and cycling great Davis Phinney as our keynote speaker for the event.”

Phinney, diagnosed with Parkinson’s disease in 2000 at the age of 40, founded the Davis Phinney Foundation in 2004; a national organization, based in Boulder, CO. Today, Phinney is both a role model in the cycling community and an inspiration to the estimated 1.5 million Americans and 10 million worldwide who are currently living with the disease. Tens of thousands of people living with this disease have been directly touched by one of the Davis Phinney Foundation programs or through Davis Phinney’s inspirational message: “it is possible to live well with Parkinson’s today.” For more information, visit: http://www.davisphinneyfoundation.org.

In 2009, it was announced that Phinney’s foundation had joined forces with Medtronic, Inc. (one of the sponsors of the CBSA Awards Dinner) to raise awareness among individuals with Parkinson's disease and their caregivers about how to improve their lives today. Together, through educational programs focused on daily victories over Parkinson’s disease, they aim to increase understanding about the importance of exercise, living a healthy lifestyle and the consideration of various treatment options. Phinney has found relief from debilitating tremors and stiff limbs and joints after receiving Medtronic Deep Brain Stimulation (DBS) Therapy. For more information about Phinney’s experience with DBS, visit:http://www.medtronicdbs.com/parkinsons/personal-stories/davis-phinney/index.htm.

The Awards Dinner, emceed by 850 KOA Morning News Anchor Steffan Tubbs, will begin with a cocktail reception followed by dinner and a dynamic program. CBSA will first recognize those companies and individuals who are making a significant difference in Colorado’s vibrant bioscience industry. The Boettcher Foundation will then present the 2014 Class of Boettcher Investigators in the Webb-Waring Biomedical Research Program. The event closes with Phinney’s keynote.

This year’s Bioscience Industry Awards include:

* Lifetime Achievement
* Company of the Year
* Rising Star
* Institute Leadership
* Business Partner of the Year
* Educator of the Year
* Volunteer of the Year
 * Chairman’s Award

Tickets for the Awards Dinner are available for purchase at the CBSA website. Individual tickets are $150. Tables (8 seats) are available for $1,250 for CBSA members and $1,500 for non-CBSA members. Please note: the Awards Dinner was a sellout event last year, so do not delay securing arrangements. Visit:http://www.cobioscience.com/events-calendar/awards-dinner-2014.  

Sponsorships for the Awards Dinner are also still available. Those interested in sponsorships should contact Tracey Nilson at tnilson@cobioscience.com no later than October 24. Sponsors, as of the date of this release, include: Boettcher Foundation; Cooley, LLP; Fisher Scientific, Fitzsimons Redevelopment Authority, Medtronic and Terumo BCT. 

Link to the Business Wire Release

Link to the Pitch Engine Social Media Release
4:49 pm edt          Comments

Wednesday, October 8, 2014

InnovatioNews: 'CID4 awards $200K to Sapphire Technology to advance development of dental instruments'
Quoting from today's posting:

"The Colorado Institute for Drug, Device and Diagnostic Development (CID4) awarded $200,000 to Denver-based Sapphire Technology LLC to develop the company’s proprietary dental instruments.

Sapphire is a development-stage dental device company advancing proprietary sapphire-tipped instruments for use in dental procedures involving photo-cured, resin composite filling and restoration materials.

'We are extremely excited about our investment and involvement in Sapphire Technology,' said Kevin Smith, CID4 president and CEO."
 
Link to InnovatioNews
5:39 pm edt          Comments

Denver Post: 'Denver-based Sapphire Technology gets funding for gemstone-tipped dental instruments'
Quoting from yesterday's posting by Laura Keeney:

"Your dental visit may soon have a lot more bling.

Denver-based Sapphire Technology LLC on Tuesday was awarded $200,000 from the Colorado Institute for Drug, Device and Diagnostic Development, or CID4, for continued development of its dental instruments made with sapphires.

Sapphire, which is a gemstone variety of corundum, ranks at the top of the Mohs scale of mineral hardness — the universal standard to measure the hardness of gemstones and minerals.

The gemstone has been in the news recently amid speculation that Apple might use highly scratch-resistant glass made of sapphires for its new iPhone screens.

But what does this have to do with dental work?"
 
Link to the Denver Post
5:33 pm edt          Comments

Wednesday, September 17, 2014

Four Colorado Bioscience Companies Present at the Inaugural White Hat Life Science Investor Conference in Phoenix
 
Colorado BioScience Association (CBSA) congratulates the four Colorado headquartered companies selected to present at the inaugural White Hat Life Science Investor Conference being held September 17 and 18 at the Grand Hyatt in Phoenix, AZ. The announcement is made by April Giles, CBSA President and CEO, who says, “We’re excited to be a partner in the 2014 White Hat Life Science Investor Conference and to help showcase three of Colorado’s promising bioscience companies during the event.” The participating Colorado companies include EndoShape, Fluonic, ValveXchange and ViroCyt.

The conference, spearheaded by the Arizona BioIndustry Association (AZBio), is presented by the National Venture Capital Association and leading life science associations of the Rocky Mountain Southwest Region, including the CBSA. This conference is showcasing 34 of the region’s top life science companies to interested investors including business development professionals from large pharmaceutical, biotechnology, medical device and diagnostic companies.

“The Rocky Mountain and Southwest Regions have become increasingly recognized for their growth in the bioscience and heath care innovations. The White Hat Life Science Investor Conference will act as another opportunity to highlight the work being done in Colorado and the surrounding region while at the same time bringing new potential partners and investors into our community,” Giles said. 

Colorado bioscience companies selected to present in the 2014 White Hat Investor Conference:

EndoShape, Inc., Boulder – EndoShape’s mission is to commercialize novel medical devices based on its proprietary polymer technology. EndoShape is focused on the coil embolization and occlusion market. EndoShape is currently commercializing the Medusa™ Vascular Plug which is FDA 510(k) cleared for sale in the United States. Visit, http://www.endoshape.com.

Fluonic, Inc., Boulder - Fluonic is a privately held medical device company dedicated to making infusion drug delivery safer for patients through the development of a new generation of infusion devices and information systems, driven by a breakthrough MEMS flow sensor technology. Fluonic infusion products improve patients’ safety and compliance while improving medical staff productivity and reducing costs, which will set a new standard of care for the industry. Visit,http://fluonic.com.

* ValveXchange, Inc. – Greenwood Village – ValveXchange (VXi) is dedicated to improving the lives of patients requiring heart valve replacements. VXi is developing a two-piece bioprosthetic tissue valve system that resolves the long standing compromises between conventional mechanical and tissue-based prosthetic valves. Unlike today’s transcatheter valves, the VXi technology is Without Compromise. The VXi exchangeable valve system is being designed to offer leaflet exchange, as well as the original implant, without open-heart surgery and without the safety and longevity compromises of transcatheter approaches. Visit: http://www.valvexchange.com.

ViroCyt, LLC, Boulder - ViroCyt, LLC was created in late 2012 to focus on the commercialization of novel technologies that enable rapid quantification of viruses, such as the Virus Counter® 3100. The Company’s mission is to provide the tools that deliver meaningful improvements to critical biotechnology processes such as vaccine manufacturing, protein expression, antiviral development and other settings where viruses play a significant role. Visit, http://www.virocyt.com.

For more information and a complete listing of presenting companies, visit the conference website at http://www.azbio.org/white-hat-investors-2014

Link to the related PitchEngine Social Media Release
3:25 pm edt          Comments

2014.10.01 | 2014.09.01 | 2014.07.01 | 2014.06.01 | 2014.05.01 | 2014.04.01 | 2014.03.01 | 2013.09.01 | 2013.08.01 | 2012.12.01 | 2012.09.01 | 2012.07.01 | 2012.06.01 | 2012.03.01 | 2012.02.01 | 2011.12.01 | 2011.11.01 | 2011.10.01 | 2011.09.01 | 2011.06.01 | 2011.05.01 | 2010.12.01 | 2010.09.01 | 2010.08.01 | 2010.07.01 | 2010.05.01 | 2010.04.01 | 2010.03.01 | 2010.02.01 | 2010.01.01

Link to web log's RSS file

The Absolutely PR Blog is listed on Blog Catalog:

http://www.blogcatalog.com/blogs/absolutely-pr-blog.html